ASX - By Stock
|
BOT |
Re:
Ann: FDA Approves Sofdra
|
|
stockrock
|
484 |
146K |
19 |
21/06/24 |
21/06/24 |
ASX - By Stock
|
484
|
146K
|
19
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Trading Halt
|
|
stockrock
|
339 |
111K |
29 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
339
|
111K
|
29
|
|
ASX - By Stock
|
MSB |
Re:
Australian newspaper article
|
|
stockrock
|
225 |
80K |
41 |
11/06/24 |
11/06/24 |
ASX - By Stock
|
225
|
80K
|
41
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
stockrock
|
1.0K |
416K |
60 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
1.0K
|
416K
|
60
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
stockrock
|
1.0K |
416K |
41 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
1.0K
|
416K
|
41
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
stockrock
|
5.4K |
2.7M |
23 |
21/05/24 |
21/05/24 |
ASX - By Stock
|
5.4K
|
2.7M
|
23
|
|
ASX - By Stock
|
WBT |
Re:
Running discussion on SP
|
|
stockrock
|
8.2K |
3.2M |
8 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
8.2K
|
3.2M
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Appendix 3Y for Eric Rose
|
|
stockrock
|
45 |
21K |
1 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
45
|
21K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Appendix 3Y for Eric Rose
|
|
stockrock
|
45 |
21K |
63 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
45
|
21K
|
63
|
|
ASX - By Stock
|
RCR |
Re:
General Discussion
|
|
stockrock
|
754 |
204K |
14 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
754
|
204K
|
14
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
stockrock
|
14K |
6.7M |
30 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
14K
|
6.7M
|
30
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
stockrock
|
14K |
6.7M |
34 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
14K
|
6.7M
|
34
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
stockrock
|
119 |
50K |
51 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
119
|
50K
|
51
|
|
ASX - By Stock
|
TIE |
Re:
Ann: Notice that defeating conditions to takeover bid freed
|
|
stockrock
|
2 |
823 |
5 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
2
|
823
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast stock(rock)-take March 2024
|
|
stockrock
|
273 |
124K |
112 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
273
|
124K
|
112
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast stock(rock)-take March 2024
|
|
stockrock
|
273 |
124K |
73 |
07/04/24 |
07/04/24 |
ASX - By Stock
|
273
|
124K
|
73
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
stockrock
|
1.0K |
416K |
83 |
06/04/24 |
06/04/24 |
ASX - By Stock
|
1.0K
|
416K
|
83
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
stockrock
|
1.0K |
416K |
51 |
06/04/24 |
06/04/24 |
ASX - By Stock
|
1.0K
|
416K
|
51
|
|
ASX - By Stock
|
MSB |
Re:
2024 Here we go again.
|
|
stockrock
|
644 |
259K |
8 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
644
|
259K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
2024 Here we go again.
|
|
stockrock
|
644 |
259K |
3 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
644
|
259K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast stock(rock)-take March 2024
|
|
stockrock
|
273 |
124K |
51 |
30/03/24 |
30/03/24 |
ASX - By Stock
|
273
|
124K
|
51
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
stockrock
|
1.0K |
416K |
44 |
30/03/24 |
30/03/24 |
ASX - By Stock
|
1.0K
|
416K
|
44
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast stock(rock)-take March 2024
|
|
stockrock
|
273 |
124K |
39 |
30/03/24 |
30/03/24 |
ASX - By Stock
|
273
|
124K
|
39
|
|
ASX - By Stock
|
MSB |
Mesoblast stock(rock)-take March 2024
|
|
stockrock
|
273 |
124K |
214 |
29/03/24 |
29/03/24 |
ASX - By Stock
|
273
|
124K
|
214
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
stockrock
|
1.0K |
416K |
21 |
29/03/24 |
29/03/24 |
ASX - By Stock
|
1.0K
|
416K
|
21
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
stockrock
|
1.0K |
416K |
5 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
1.0K
|
416K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
stockrock
|
1.0K |
416K |
12 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
1.0K
|
416K
|
12
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
stockrock
|
1.0K |
416K |
46 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
1.0K
|
416K
|
46
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
stockrock
|
549 |
179K |
24 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
549
|
179K
|
24
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
stockrock
|
549 |
179K |
39 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
549
|
179K
|
39
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
stockrock
|
549 |
179K |
24 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
549
|
179K
|
24
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
stockrock
|
549 |
179K |
18 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
549
|
179K
|
18
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
stockrock
|
549 |
179K |
49 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
549
|
179K
|
49
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Grants Orphan Drug Designation for Revascor
|
|
stockrock
|
272 |
102K |
67 |
24/02/24 |
24/02/24 |
ASX - By Stock
|
272
|
102K
|
67
|
|
ASX - By Stock
|
IVZ |
Re:
Ann: Gas Sales MOU Signed for 500MW Gas to Power Project
|
|
stockrock
|
306 |
103K |
20 |
18/12/23 |
18/12/23 |
ASX - By Stock
|
306
|
103K
|
20
|
|
ASX - By Stock
|
WBT |
Re:
Weebit - 2023 and beyond
|
|
stockrock
|
2.9K |
1.4M |
71 |
16/12/23 |
16/12/23 |
ASX - By Stock
|
2.9K
|
1.4M
|
71
|
|
ASX - By Stock
|
WBT |
Re:
Charts
|
|
stockrock
|
4.9K |
2.0M |
10 |
15/12/23 |
15/12/23 |
ASX - By Stock
|
4.9K
|
2.0M
|
10
|
|
ASX - By Stock
|
IVZ |
Re:
Ann: Trading Halt
|
|
stockrock
|
411 |
176K |
4 |
15/12/23 |
15/12/23 |
ASX - By Stock
|
411
|
176K
|
4
|
|
ASX - By Stock
|
IVZ |
Re:
Ann: Trading Halt
|
|
stockrock
|
411 |
176K |
15 |
15/12/23 |
15/12/23 |
ASX - By Stock
|
411
|
176K
|
15
|
|
ASX - By Stock
|
WBT |
Re:
Charts
|
|
stockrock
|
4.9K |
2.0M |
12 |
13/12/23 |
13/12/23 |
ASX - By Stock
|
4.9K
|
2.0M
|
12
|
|
ASX - By Stock
|
WBT |
Re:
Charts
|
|
stockrock
|
4.9K |
2.0M |
13 |
13/12/23 |
13/12/23 |
ASX - By Stock
|
4.9K
|
2.0M
|
13
|
|
ASX - By Stock
|
WBT |
Re:
Charts
|
|
stockrock
|
4.9K |
2.0M |
1 |
13/12/23 |
13/12/23 |
ASX - By Stock
|
4.9K
|
2.0M
|
1
|
|
ASX - By Stock
|
WBT |
Re:
Charts
|
|
stockrock
|
4.9K |
2.0M |
24 |
13/12/23 |
13/12/23 |
ASX - By Stock
|
4.9K
|
2.0M
|
24
|
|
ASX - By Stock
|
IVZ |
Re:
Ann: Trading Halt
|
|
stockrock
|
411 |
176K |
32 |
13/12/23 |
13/12/23 |
ASX - By Stock
|
411
|
176K
|
32
|
|
ASX - By Stock
|
IVZ |
Re:
IVZ Share Price
|
|
stockrock
|
21K |
7.1M |
9 |
07/12/23 |
07/12/23 |
ASX - By Stock
|
21K
|
7.1M
|
9
|
|
ASX - By Stock
|
IVZ |
Re:
Discovery
|
|
stockrock
|
209 |
76K |
6 |
07/12/23 |
07/12/23 |
ASX - By Stock
|
209
|
76K
|
6
|
|
ASX - By Stock
|
IVZ |
Re:
Discovery
|
|
stockrock
|
209 |
76K |
3 |
07/12/23 |
07/12/23 |
ASX - By Stock
|
209
|
76K
|
3
|
|
ASX - By Stock
|
IVZ |
Re:
Discovery
|
|
stockrock
|
209 |
76K |
6 |
07/12/23 |
07/12/23 |
ASX - By Stock
|
209
|
76K
|
6
|
|
ASX - By Stock
|
IVZ |
Re:
Discovery
|
|
stockrock
|
209 |
76K |
13 |
07/12/23 |
07/12/23 |
ASX - By Stock
|
209
|
76K
|
13
|
|
ASX - By Stock
|
IVZ |
Re:
Discovery
|
|
stockrock
|
209 |
76K |
14 |
07/12/23 |
07/12/23 |
ASX - By Stock
|
209
|
76K
|
14
|
|